MISSOURI CITY, Texas – April 10, 2002 – The Texas Board of Chiropractic Examiners has determined that MicroLight Corporation of America’s ML 830® low-level laser is within the scope of chiropractic care, the company announced today.
“This represents a major breakthrough in the treatment of Carpal Tunnel Syndrome in the chiropractic profession,” said MicroLight President Mike Barbour. “This will allow more than 4,000 chiropractors in the state of Texas access to the ML 830® patented laser technology.”
MicroLight is the only company that has received FDA clearance to market low-level laser therapy for non-surgical treatment of Carpal Tunnel Syndrome, or CTS. CTS is the No. 1 repetitive-stress injury problem in the workforce, costing the U.S. health care industry more than $10 billion annually.